Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

Source:http://linkedlifedata.com/resource/pubmed/id/15801816

J. Med. Chem. 2005 Apr 7 48 7 2258-61

Download in:

View as

Triples

General Info

PMID
15801816